niftify.in

niftify.in

Latest Aarti Drugs News

All-In-One Aarti Drugs Stock News Hub: Explore the latest Aarti Drugs stock and industry news. Quickly find information on Aarti Drugs stock buybacks,Aarti Drugs results, Aarti Drugs company analysis, Aarti Drugs live prices, Aarti Drugs dividends, Aarti Drugs bonus share, board meetings, lifetime highs, Aarti Drugs targets, lows, and growth stories with AI.

Aarti Drugs announced that the United States Food and Drug Administration (USFDA) conducted an inspection at its active pharmaceutical ingredient (API) manufacturing facility located in MIDC, Tarapur, Maharashtra.
Business Standard

Business Standard

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

Aarti Drugs announced that the United States Food and Drug Administration (USFDA) conducted an inspection at its active pharmaceutical ingredient (API) manufacturing facility located in MIDC, Tarapur, Maharashtra.

Sat, Sep 21, 2024

From Aarti Drugs and other companies carrying out share buybacks to VST Industries issuing 10 bonus shares, these are the corporate actions lined up for the upcoming week.
CNBC TV18

CNBC TV18

Bonus, Buybacks, Dividend Record Dates: Last chance to avail 10 free shares, participate in buybacks

From Aarti Drugs and other companies carrying out share buybacks to VST Industries issuing 10 bonus shares, these are the corporate actions lined up for the upcoming week.

Mon, Sep 2, 2024

Aarti Drugs Share Price: Aarti Drugs shares surged 5% to Rs 634.90 on BSE after announcing a Rs 60 crore buyback of 6.65 lakh shares at Rs 900 each. The stock has risen 14% in the past year.
The Economic Times

The Economic Times

Aarti Drugs shares zoom 5% on Rs 60 crore buyback announcement

Aarti Drugs Share Price: Aarti Drugs shares surged 5% to Rs 634.90 on BSE after announcing a Rs 60 crore buyback of 6.65 lakh shares at Rs 900 each. The stock has risen 14% in the past year.

Tue, Aug 27, 2024

At meeting held on 26 August 2024
Business Standard

Business Standard

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

At meeting held on 26 August 2024

Mon, Aug 26, 2024

Aarti Drugs has set September 5 as the record date for its Rs 59.85 crore share buyback. The company will repurchase up to 6,65,000 shares at Rs 900 each, a 48% premium on Monday's BSE closing price. The buyback represents 0.72% of its total equity.
The Economic Times

The Economic Times

Aarti Drugs announces record date for Rs 60 crore share buyback

Aarti Drugs has set September 5 as the record date for its Rs 59.85 crore share buyback. The company will repurchase up to 6,65,000 shares at Rs 900 each, a 48% premium on Monday's BSE closing price. The buyback represents 0.72% of its total equity.

Mon, Aug 26, 2024

Aarti Drugs surged 7.57% to Rs 606.35 after the pharma company announced that its board has approved share buyback of up to Rs 59.85 crore at a price of Rs 900 per equity share.
Business Standard

Business Standard

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

Aarti Drugs surged 7.57% to Rs 606.35 after the pharma company announced that its board has approved share buyback of up to Rs 59.85 crore at a price of Rs 900 per equity share.

Mon, Aug 26, 2024

Buyback price has been fixed as ₹900 per share, which is at a 60% premium to the current market levels.
CNBC TV18

CNBC TV18

Buyback Alert: Aarti Drugs to repurchase shares at a 60% premium

Buyback price has been fixed as ₹900 per share, which is at a 60% premium to the current market levels.

Mon, Aug 26, 2024

Stock Market today: Aarti Drugs share price gained more than 12% in morning trades on Thursday. The company announced that it will considering a share buy back proposal on 26 August.
Mint

Mint

Aarti Drugs share price rises more than 12%: To consider share buyback proposal on 26 August

Stock Market today: Aarti Drugs share price gained more than 12% in morning trades on Thursday. The company announced that it will considering a share buy back proposal on 26 August.

Thu, Aug 22, 2024